Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Donato

Showing results (11-20 of 90) with videos related to

Pageof 9
Sort By:
Pathogens (Basel, Switzerland)|February 25, 2023
The Impact of Antiviral Treatment of Hepatitis B Virus after Kidney Transplant and the Latest InsightsFabrizio Fabrizi, Maria Francesca Donato, Federica Tripodi, et al.
Antiviral Therapy|October 13, 2005
The prevalence, clinical features and response to antiviral therapy of patients with chronic hepatitis C who are seropositive for liver-kidney microsome type 1 antibodiesValentina Monti, Alessio Aghemo, Maria Grazia Rumi, et al.
Gut|January 27, 2007
Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver diseaseMirella Fraquelli, Cristina Rigamonti, Giovanni Casazza, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 31, 2014
Bridging all oral DAA therapy from wait time to post-liver transplant to improve HCV eradication?Maria Francesca Donato, Sara Monico, Federica Malinverno, et al.
Cancer|July 25, 2003
The clinical and pathogenetic significance of estrogen receptor-beta expression in chronic liver diseases and liver carcinomaMassimo Iavarone, Pietro Lampertico, Chiara Seletti, et al.
The International Journal of Artificial Organs|March 1, 2013
Antiviral therapy of symptomatic HCV-mixed cryoglobulinemia after liver transplant: case report and literature reviewMaria Francesca Donato, Giovanni Banfi, Donata Cresseri, et al.
The International Journal of Artificial Organs|January 3, 2013
Remission of HCV-associated glomerulonephritis with pegylated ifn and ribavirin therapy after liver transplantation: case report and literature reviewMaria Francesca Donato, Fabrizio Fabrizi, Giovanni Battista Fogazzi, et al.
Frontiers in Endocrinology|March 20, 2024
Assessment of hepatic fibrosis with non-invasive indices in subjects with diabetes before and after liver transplantationValeria Grancini, Irene Cogliati, Gianfranco Alicandro, et al.
Antiviral Therapy|July 7, 2009
The pattern of pegylated interferon-alpha2b and ribavirin treatment failure in cirrhotic patients depends on hepatitis C virus genotypeAlessio Aghemo, Maria Grazia Rumi, Sara Monico, et al.
International Journal of Environmental Research and Public Health|August 10, 2019
Upper Limb Work-Related Musculoskeletal Disorders in Operating Room Nurses: A Multicenter Cross-Sectional StudyMarco Clari, Giacomo Garzaro, Matteo Di Maso, et al.
Pageof 9

Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
Pathogens (Basel, Switzerland)|February 25, 2023
The Impact of Antiviral Treatment of Hepatitis B Virus after Kidney Transplant and the Latest InsightsFabrizio Fabrizi, Maria Francesca Donato, Federica Tripodi, et al.
Antiviral Therapy|October 13, 2005
The prevalence, clinical features and response to antiviral therapy of patients with chronic hepatitis C who are seropositive for liver-kidney microsome type 1 antibodiesValentina Monti, Alessio Aghemo, Maria Grazia Rumi, et al.
Gut|January 27, 2007
Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver diseaseMirella Fraquelli, Cristina Rigamonti, Giovanni Casazza, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 31, 2014
Bridging all oral DAA therapy from wait time to post-liver transplant to improve HCV eradication?Maria Francesca Donato, Sara Monico, Federica Malinverno, et al.
Cancer|July 25, 2003
The clinical and pathogenetic significance of estrogen receptor-beta expression in chronic liver diseases and liver carcinomaMassimo Iavarone, Pietro Lampertico, Chiara Seletti, et al.
The International Journal of Artificial Organs|March 1, 2013
Antiviral therapy of symptomatic HCV-mixed cryoglobulinemia after liver transplant: case report and literature reviewMaria Francesca Donato, Giovanni Banfi, Donata Cresseri, et al.
The International Journal of Artificial Organs|January 3, 2013
Remission of HCV-associated glomerulonephritis with pegylated ifn and ribavirin therapy after liver transplantation: case report and literature reviewMaria Francesca Donato, Fabrizio Fabrizi, Giovanni Battista Fogazzi, et al.
Frontiers in Endocrinology|March 20, 2024
Assessment of hepatic fibrosis with non-invasive indices in subjects with diabetes before and after liver transplantationValeria Grancini, Irene Cogliati, Gianfranco Alicandro, et al.
Antiviral Therapy|July 7, 2009
The pattern of pegylated interferon-alpha2b and ribavirin treatment failure in cirrhotic patients depends on hepatitis C virus genotypeAlessio Aghemo, Maria Grazia Rumi, Sara Monico, et al.
International Journal of Environmental Research and Public Health|August 10, 2019
Upper Limb Work-Related Musculoskeletal Disorders in Operating Room Nurses: A Multicenter Cross-Sectional StudyMarco Clari, Giacomo Garzaro, Matteo Di Maso, et al.
Pageof 9